Health Care & Life Sciences » Pharmaceuticals | Harbin Pharmaceutical Group Co. Ltd.

Harbin Pharmaceutical Group Co. Ltd. A | Mutual Funds

Mutual Funds that own Harbin Pharmaceutical Group Co. Ltd. A

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
14,091,840
0.56%
8,122,040
1.22%
12/31/2017
Nanfang CSI 500 ETF
6,208,411
0.25%
-668,600
0.17%
12/31/2017
5,467,208
0.22%
3,655,608
0.81%
12/31/2017
4,732,765
0.19%
-1,738,841
0.56%
12/31/2017
Guotai Jinlong Bond Securities Investment Fund
3,387,450
0.14%
3,387,450
1.13%
12/31/2016
3,206,765
0.13%
1,916,665
1.33%
12/31/2017
3,043,200
0.12%
1,501,600
0.8%
12/31/2017
2,580,000
0.1%
0
1.96%
12/31/2017
2,394,449
0.1%
0
0.68%
12/31/2017
Chang Xin Jin Li Fund
2,367,800
0.1%
1,787,000
0.72%
12/31/2017

About Harbin Pharmaceutical Group Co.

View Profile
Address
No. 7 Qunli Avenue
Harbin Heilongjiang 150070
China
Employees -
Website http://www.hayao.com
Updated 07/08/2019
Harbin Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, wholesale, and retail of pharmaceutical products. It pharmaceutical covers chemical raw materials, chemical agents, biological agents, Chinese medicine, and health care products. It specializes in anti-infection, cardiovascular and cerebrovascular, cold medicine, digestive system, anti-tumor drugs, and nutritional supplements.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.